TeraView
News section

News Releases

24 Feb 10real time in‑line measurement of tablet coating thickness variability within a coating pan
 TeraView, along with its partners Oystar Manesty, Liverpool University and Cambridge University have successfully demonstrated the ability to measure in-line the coating thickness distribution on a batch of tablets within a production scale coating pan in real time.
6 Jan 10Terahertz sensors demonstrate the potential for detection of explosives hidden by clothing and shoes
 TeraView’s Terahertz people screening technology has the potential to play an important role in the detection of explosives such as that used in the attempted bombing near Detroit
12 Aug 09TeraView Contract Analytical and Development Services
 Teraview has recently started to offer a “fee for service” approach to the development of solid dosage systems. TeraView’s unique technology allows us to quickly and non-destructively generate 3D product images and to use this information to measure critical quality attributes and thus improve the product (Tablets, beads, capsules, wafers, patches etc). No project is too large!
11 Jun 09TeraView secures Iowa State University Order
 TeraView has been awarded a contract by Iowa State University (ISU) to supply an integrated state-of-the-art terahertz system. The system, located within a terahertz research facility, will find use across a wide spectrum of science and engineering fields, including non-destructive testing, chemistry, biomedical and environmental engineering
28 Nov 08TeraView and Oystar Manesty leads consortium developing real time monitoring of pharmaceutical manufacturing processes
 TeraView Ltd, Oystar Manesty and the Universities of Cambridge and Liverpool are using Terahertz technology for the real time control of pharmaceutical manufacturing processes.
15 Oct 08Goodrich selects TeraView technology for use in airborne chemical agent detection in defense and homeland security applications
 TeraView signs commercial agreement with Goodrich to support Goodrich’s terahertz product deployment plans over the next several years.
7 Sep 08Louise Ho awarded prestigious Conference Analytical Science Award at BPC 08
 Louise Ho, University of Otago, New Zealand is awarded the prestigious JPAG Conference Analytical Science Award at this years British Pharamceutical Conference.
30 Jun 08TeraView is granted its 50th patent for pioneering work in terahertz technology and its applications
 TeraView’s proprietary technology and know-how has rapidly expanded to support the needs of our customers and partners in a range of industries.
6 May 08Another world first - TeraView wins contracts to support partners with innovative explosive detection system
 TeraView uses its years of experience working with US & UK government agencies and industrial partners to demonstrate prototypes for defense and homeland security applications.
7 Apr 08Better prediction and control of drug release is achieved by using terahertz imaging to map tablet coating thickness AND density
 The benefits of terahertz through accelerated product development, de-risked and rapid scale up into manufacture and maintenance of in-spec products is further endorsed by a recent study conducted by the Universities of Dusseldorf and Otago.
3 Mar 08New terahertz spectrometer from TeraView – filling the ‘gap’ in the spectroscopy toolkit
 TeraView Ltd has developed a new terahertz spectrometer. Complementing TeraView’s existing range of unique imaging solutions, the Spectra 3000 is the world’s first commercial terahertz spectrometer capable of performing both transmission and attenuated total reflection (ATR) measurements.
25 Jan 08Another world first - TeraView demonstrates capability for on-line tablet inspection
 TeraView uses its years of experience working with the pharmaceutical industry and its proprietary terahertz platform to demonstrate real time measurements of tablet coating thickness and other critical quality attributes of solid dosage forms.
29 Nov 07Accelerating solid dosage development and ensuring in spec product with terahertz imaging – recent case studies
 TeraView’s proprietary technology and expertise have now been successfully applied to define product and process specifications that affect the performance of solid dosage forms. A series of successful case studies with the pharmaceutical industry and Food and Drug Administration (FDA) were used to illustrate the benefits to the industry in terms of reducing development time, ensuring rapid scale up into manufacture and maintaining in-spec product with reduced risk of regulatory non compliance.
9 Oct 07Recent FDA study suggests that Terahertz tablet imaging could replace wet dissolution testing.
 TeraView, the pioneer and leader in Terahertz technology and solutions for the pharmaceutical and life science industries, says its Terahertz imaging and spectroscopy products can be used in conjunction with wet dissolution testing to accelerate product development of tablets and capsules, and maintain in-spec performance during pharmaceutical manufacture.
8 Aug 07Another world first - TeraView and Bruker Capture the Asian Market for Terahertz
 TeraView, the pioneer and leader in Terahertz technology and solutions for the pharmaceutical, life science and analytical industries, announces that it has received orders and installed systems for key customers in Japan, Korea and China.
23 Jan 07TeraView announces first order into the Japanese pharmaceutical market
 TeraView have deployed the first commercial Terahertz imager in Japan to aid in the development of new pharmaceutical tablets and other solid dosage forms, as well as root cause analysis in manufacture.
12 Dec 06Tablet fingerprinting has role to play in fight against counterfeit drugs, says TeraView.
 50 per cent of drugs bought from the Internet are counterfeit says WHO. TeraView, the pioneer and leader in terahertz technology and solutions for the pharmaceutical and life science industry, says its terahertz imaging and spectroscopy products could be employed to help regulatory authorities, law enforcement agencies and the industry screen for counterfeit drugs.
1 Nov 06TeraView attracts senior figures from big pharma and secures second US investor
 Dr. Barrie Thorpe, formerly Executive Vice-President, Operations at Astra Zeneca, takes on only his second non-executive directorship and Dr Andrew Carr (formerly director of Amersham plc) has joined as non-executive chairman.
4 Jan 06TeraView Strengthens: Honours and Additions to the Executive Management Team
 TeraView Ltd, the world leader in commercial exploitation of Terahertz technology, is delighted to announce that Michael Pepper, Chief Scientific Officer and Co-Founder at TeraView Ltd, and Professor of Physics at the University of Cambridge, has been knighted in the New Year’s Honours list.
7 Jul 05Ultra-low threshold current THz quantum cascade lasers with buried double-metal waveguide structures
 An Anglo-French team composed of TeraView Ltd., Cambridge University, the University of Paris 7, and Thales R&T, has reported the operation of quantum cascade lasers (QCLs) emitting at 2.8 Terahertz (THz) with a threshold current of 19 mA at 4K (see S. Dhillon et al., Applied Physics Letters, August 1, 2005 issue), the lowest threshold ever measured without the help of intense magnetic field.

Page: 1 | 2

 
| Home | About Us | Markets | News | Products | Services | Terahertz | Sitemap |
| E: enquiries@teraview.com | T: +44(0)1223 435380 |